• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zura Bio Limited - Class A Ordinary shares (NQ:ZURA)

6.360 -0.090 (-1.40%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 529,196
Open 6.460
Bid (Size) 6.150 (1,000)
Ask (Size) 6.700 (100)
Prev. Close 6.450
Today's Range 6.128 - 6.520
52wk Range 0.9700 - 6.630
Shares Outstanding 62,064,270
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer
January 21, 2026
From Zura Bio Limited
Via Business Wire
News headline image
Zura Bio Reports Business Updates and Outlook for 2026
January 12, 2026
From Zura Bio Limited
Via Business Wire

Performance

YTD
+14.6%
+14.6%
1 Month
+41.3%
+41.3%
3 Month
+72.4%
+72.4%
6 Month
+287.8%
+287.8%
1 Year
+269.8%
+269.8%

More News

Read More
News headline image
Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates
November 13, 2025
From Zura Bio Limited
Via Business Wire
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
October 01, 2025
Via Chartmill
News headline image
Here are the top movers in Tuesday's session. ↗
September 30, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
September 30, 2025
Via Benzinga
News headline image
These stocks are moving in today's session ↗
September 30, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
September 29, 2025
Via Benzinga
News headline image
Top stock movements in today's session. ↗
September 29, 2025
Via Chartmill
News headline image
Wondering what's happening in today's pre-market session? ↗
September 29, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
September 29, 2025
Via Benzinga
News headline image
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗
September 29, 2025
Via Benzinga
News headline image
Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference
August 20, 2025
From Zura Bio Limited
Via Business Wire
News headline image
Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
August 14, 2025
From Zura Bio Limited
Via Business Wire
News headline image
Novartis Drug Shows Improvement In Sjögren's Disease In Late-Stage Trials: Analyst Deems Data Positive For Zura Bio As Well ↗
August 11, 2025
Via Stocktwits
News headline image
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 17, 2025
From Zura Bio
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
July 17, 2025
Via Benzinga
News headline image
Zura Bio Announces Chief Financial Officer Transition
July 01, 2025
From Zura Bio Limited
Via Business Wire
News headline image
Zura Bio to Present at the Jefferies Global Healthcare Conference
May 27, 2025
From Zura Bio Limited
Via Business Wire
News headline image
Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa
May 20, 2025
From Zura Bio Limited
Via Business Wire
News headline image
Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates
May 08, 2025
From Zura Bio Limited
Via Business Wire
News headline image
Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates
March 25, 2025
From Zura Bio Limited
Via Business Wire
News headline image
Zura Bio to Present at the Leerink Partners Global Healthcare Conference
February 24, 2025
From Zura Bio Limited
Via Business Wire
News headline image
Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis
December 23, 2024
From Zura Bio Limited
Via Business Wire
News headline image
Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference
November 25, 2024
From Zura Bio Limited
Via Business Wire

Frequently Asked Questions

Is Zura Bio Limited - Class A Ordinary shares publicly traded?
Yes, Zura Bio Limited - Class A Ordinary shares is publicly traded.
What exchange does Zura Bio Limited - Class A Ordinary shares trade on?
Zura Bio Limited - Class A Ordinary shares trades on the Nasdaq Stock Market
What is the ticker symbol for Zura Bio Limited - Class A Ordinary shares?
The ticker symbol for Zura Bio Limited - Class A Ordinary shares is ZURA on the Nasdaq Stock Market
What is the current price of Zura Bio Limited - Class A Ordinary shares?
The current price of Zura Bio Limited - Class A Ordinary shares is 6.360
When was Zura Bio Limited - Class A Ordinary shares last traded?
The last trade of Zura Bio Limited - Class A Ordinary shares was at 01/23/26 04:00 PM ET
What is the market capitalization of Zura Bio Limited - Class A Ordinary shares?
The market capitalization of Zura Bio Limited - Class A Ordinary shares is 394.73M
How many shares of Zura Bio Limited - Class A Ordinary shares are outstanding?
Zura Bio Limited - Class A Ordinary shares has 395M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap